Related Experiment Video

Updated: Aug 24, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Diabetic cardiomyopathy: a metabolic perspective

Angelo Avogaro1, Saula Vigili de Kreutzenberg, Christian Negut

  • 1Division of Metabolic Diseases, Department of Clinical and Experimental Medicine, University of Padua, Padua, Italy. angelo.avogaro@unipd.it

The American Journal of Cardiology
|April 20, 2004
PubMed

Insights

Diabetes significantly increases heart risks due to metabolic changes. This study explores how amino acid disturbances in the diabetic heart affect energy and contractile proteins, offering new insights into cardiac vulnerability.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Biochemistry

Background:

  • Diabetes mellitus elevates coronary ischemic events and heart failure risk by over threefold.
  • Cardiac metabolic alterations in diabetes include reduced glucose use, lactate oxidation, and increased fatty acid metabolism.
  • Limited research exists on amino acid disturbances in the diabetic heart.

Purpose of the Study:

  • To investigate the role of amino acid alterations in diabetic cardiac dysfunction.
  • To explore the impact of these changes on cardiac energy reserves and contractile proteins.

Main Methods:

  • The study focuses on analyzing amino acid profiles within the cardiac tissue of diabetic models.
  • Investigates the correlation between specific amino acid changes and functional cardiac impairments.

Main Results:

  • Observed significant alterations in cardiac amino acid concentrations in diabetic subjects.
  • Preliminary findings suggest these amino acid disturbances may compromise energy production and protein integrity.
  • Potential link established between amino acid imbalances and reduced cardiac contractility.

Conclusions:

  • Amino acid metabolism is a critical, yet understudied, factor in diabetic heart disease.
  • Addressing amino acid imbalances could offer novel therapeutic strategies for diabetic cardiomyopathy.
  • Further research is warranted to fully elucidate the mechanisms of amino acid-related cardiac dysfunction in diabetes.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...